|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
20,000 |
0.00 |
0.00 |
20,000 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
117,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
117,000 |
0.00 |
0.00 |
117,000 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
150,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
150,000 |
0.00 |
0.00 |
150,000 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
300,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
300,000 |
0.00 |
0.00 |
300,000 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
A - A |
625,000 |
0.00 |
0.00 |
625,000 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
D - D |
44,210 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
A - A |
44,210 |
0.00 |
0.00 |
44,210 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
D - D |
15,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
A - A |
15,000 |
0.00 |
0.00 |
15,000 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
D - D |
35,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
A - A |
35,000 |
0.00 |
0.00 |
35,000 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
D - D |
25,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
A - A |
25,000 |
0.00 |
0.00 |
25,000 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
D - D |
106,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Luptakova Katarina |
|
2025-11-21 |
A - A |
106,000 |
0.00 |
0.00 |
106,000 |
|
Xilio Therapeutics, Inc. |
Brennan Kevin M. |
|
2025-11-21 |
A - A |
131,700 |
0.00 |
0.00 |
131,700 |
|
Xilio Therapeutics, Inc. |
Brennan Kevin M. |
|
2025-11-21 |
D - D |
55,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Brennan Kevin M. |
|
2025-11-21 |
A - A |
55,000 |
0.00 |
0.00 |
55,000 |
|
Xilio Therapeutics, Inc. |
Brennan Kevin M. |
|
2025-11-21 |
D - D |
25,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Brennan Kevin M. |
|
2025-11-21 |
A - A |
25,000 |
0.00 |
0.00 |
25,000 |
|
Xilio Therapeutics, Inc. |
Brennan Kevin M. |
|
2025-11-21 |
D - D |
20,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Brennan Kevin M. |
|
2025-11-21 |
A - A |
20,000 |
0.00 |
0.00 |
20,000 |